Our specialty is connecting yours

Connect. Collaborate. Care.

Skipta is the leading social network of specialized online medical communities for consultation, communication and information exchange between licensed health care professionals within a private and secure platform. Register for your community today!

Consult with your Colleagues

  • Cardiologist Connect 12/10/2019
    Cardiology Options for Patient With History of Heart Disease A 55-year-old female presents with an extended history of heart disease. Using thallim scintigraphy, a large and nonreversible anterior septal segment defect was found. Because the myocardium was determined to be nonviable, the woman was to be evaluated for a cardiac transplant.
    49 0 2
    Show More

Compete Against Your Peers

  • Oncology Nation 10/1/2019
    Head and Neck Squamous Cell Carcinoma
    24 0 0
    Show More

Read Trending News Stories

  • Oncology Nation 12/13/2019
    Baseline 3D-ADC outperforms 2D-ADC in predicting response to treatment in patients with colorectal liver metastases OBJECTIVES: To examine the value of baseline 3D-ADC and to predict short-term response to treatment in patients with hepatic colorectal metastases (CLMs).
    12 0 0
    Show More
  • Doctor Unite 12/11/2019
    Long-Duration Oral Vancomycin to Treat Clostridioides difficile in Patients With Inflammatory Bowel Disease Is Associated With a Low Rate of Recurrence Patients with inflammatory bowel disease (IBD) are susceptible to Clostridioides difficile infections (CDIs), suffering from greater morbidity and mortality than the general population. Previous studies have proven the efficacy of oral vancomycin therapy in CDI, but there are no definitive guidelines to treat patients with IBD.
    18 0 1
    Show More
  • Neurologist Connect 12/10/2019
    Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial BACKGROUND: More than a third of patients with epilepsy are treatment resistant, and thus new, more effective therapies to achieve seizure freedom are needed. Cenobamate (YKP3089), an investigational antiepileptic drug, has shown broad-spectrum anticonvulsant activity in preclinical studies and seizure models.
    11 0 0
    Show More

    Let's Connect

    Please enter your information below and we will contact you.
    First Name
    Last Name
    Phone Number
    I'm a
    Company Name
    Add a message